Chardan Capital Markets Starts Kalaris (KLRS) at Buy Dec 23, 2025 04:42AM
Kalaris (KLRS) PT Raised to $26 at Citizens on 'TH103's differentiated profile' Dec 18, 2025 04:34AM
Kalaris' (KLRS) TH103 Could Be a Meaningful Player - Citizens Nov 25, 2025 04:07AM
Kalaris to Present at Noble Capital Markets 21st Annual Emerging Growth Equity Conference Nov 24, 2025 08:00AM
Raymond James Reiterates Strong Buy Rating on Kalaris (KLRS) Nov 18, 2025 04:28AM


Nov 12, 2025 05:01PM Kalaris Therapeutics (KLRS) Misses Q3 EPS by 64c
Nov 12, 2025 09:46AM Raymond James Defends Kalaris (KLRS) Amid 3pct Drop: 'We continue to like this set up and recommend purchase'
Nov 3, 2025 02:34AM Citizens Starts Kalaris (KLRS) at Market Outperform
Aug 13, 2025 07:13PM Kalaris Therapeutics (KLRS) Misses Q2 EPS by 61c
Jul 23, 2025 03:50AM Piper Sandler Assumes Kalaris (KLRS) at Neutral
Jul 10, 2025 07:29AM William Blair Reiterates Outperform Rating on Kalaris (KLRS)
May 7, 2025 06:20AM Leerink Partners Starts Kalaris (KLRS) at Outperform
Apr 8, 2025 07:58AM William Blair Starts Kalaris (KLRS) at Outperform
Apr 4, 2025 08:00AM Kalaris Therapeutics (KLRS) Appoints Leone Patterson as Chair of Audit Committee
Mar 18, 2025 04:22PM Kalaris Therapeutics (KLRS) Closes Merger with AlloVir